23andMe has sold the rights to develop a drug based on its users’ DNA

Consumer genomics firm 23andMe has signed its first deal to sell the rights to develop a new drug for inflammatory diseases to a pharmaceutical company

Source:
https://www.newscientist.com/article/2229828-23andme-has-sold-the-rights-to-develop-a-drug-based-on-its-users-dna/?utm_campaign=RSS%7CNSNS&utm_source=NSNS&utm_medium=RSS&utm_content=home